James A Shaw

Summary

Affiliation: Baker Heart Research Institute
Country: Australia

Publications

  1. doi request reprint Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque
    James A Shaw
    Department of Cardiovascular Medicine, Alfred Hospital Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central 8008, Australia
    Circ Res 103:1084-91. 2008
  2. doi request reprint Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents
    James A Shaw
    Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    Cardiovasc Revasc Med 9:218-23. 2008
  3. doi request reprint Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention
    William Chan
    Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia
    Am J Cardiol 109:478-85. 2012
  4. ncbi request reprint Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry
    Andrew E Ajani
    Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia
    Med J Aust 189:423-8. 2008
  5. doi request reprint Compliance mismatch between stenotic and distal reference segment is associated with coronary artery disease instability
    Anthony J White
    Alfred Hospital and Baker IDI Heart and Diabetes Institute, St Kilda Road Central, VIC 8008, Melbourne, Australia
    Atherosclerosis 206:179-85. 2009
  6. ncbi request reprint Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness
    Andris H Ellims
    Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia
    J Am Coll Cardiol 63:1112-8. 2014
  7. ncbi request reprint Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease
    Anthony J White
    Baker Heart Research Institute and The Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia
    Cardiovasc Res 75:813-20. 2007
  8. doi request reprint The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents
    Michelle J Butler
    Department of Cardiology at the Alfred Hospital, Melbourne, Victoria, Australia
    Am Heart J 157:899-907. 2009
  9. doi request reprint Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest
    Dion Stub
    Alfred Hospital Heart Centre, Melbourne, Victoria, Australia
    Am J Cardiol 107:522-7. 2011
  10. doi request reprint Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome
    Natalie G Lumsden
    Vascular Pharmacology and Heart Failure, Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
    Diab Vasc Dis Res 10:368-74. 2013

Collaborators

Detail Information

Publications11

  1. doi request reprint Infusion of reconstituted high-density lipoprotein leads to acute changes in human atherosclerotic plaque
    James A Shaw
    Department of Cardiovascular Medicine, Alfred Hospital Baker IDI Heart and Diabetes Institute, PO Box 6492, St Kilda Rd Central 8008, Australia
    Circ Res 103:1084-91. 2008
    ..These changes may contribute to the cardioprotective effects of HDL...
  2. doi request reprint Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents
    James A Shaw
    Department of Cardiology of The Alfred Hospital, Melbourne, Australia
    Cardiovasc Revasc Med 9:218-23. 2008
    ..RI is an independent predictor of 30-day and 12-month MACE and death after PCI in patients with stable and unstable coronary syndromes, even with widespread use of DES. eGFR should be used to help risk-stratify patients undergoing PCI...
  3. doi request reprint Usefulness of transient and persistent no reflow to predict adverse clinical outcomes following percutaneous coronary intervention
    William Chan
    Department of Cardiology, Alfred Hospital, Melbourne, Victoria, Australia
    Am J Cardiol 109:478-85. 2012
    ..0001 for all comparisons) compared to patients with normal flow. In conclusion, transient or persistent no reflow complicates approximately 1 in 20 PCIs and results in stepwise increases in in-hospital and 30-day adverse outcomes...
  4. ncbi request reprint Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry
    Andrew E Ajani
    Royal Melbourne Hospital and University of Melbourne, Melbourne, Victoria, Australia
    Med J Aust 189:423-8. 2008
    ..To examine short- and medium-term outcomes of percutaneous coronary interventions (PCIs), with a focus on comparing drug-eluting stents (DESs) with bare-metal stents (BMSs)...
  5. doi request reprint Compliance mismatch between stenotic and distal reference segment is associated with coronary artery disease instability
    Anthony J White
    Alfred Hospital and Baker IDI Heart and Diabetes Institute, St Kilda Road Central, VIC 8008, Melbourne, Australia
    Atherosclerosis 206:179-85. 2009
    ..This study aimed to investigate the hypothesis that the differential in coronary artery compliance between stenotic and adjacent arterial segments is another factor associated with unstable coronary disease...
  6. ncbi request reprint Diffuse myocardial fibrosis evaluated by post-contrast t1 mapping correlates with left ventricular stiffness
    Andris H Ellims
    Heart Centre, Alfred Hospital, Melbourne, Victoria, Australia Baker IDI Heart and Diabetes Research Institute, Melbourne, Victoria, Australia
    J Am Coll Cardiol 63:1112-8. 2014
    ....
  7. ncbi request reprint Matrix metalloproteinase-3 and coronary remodelling: implications for unstable coronary disease
    Anthony J White
    Baker Heart Research Institute and The Department of Cardiovascular Medicine, Alfred Hospital, Melbourne, Australia
    Cardiovasc Res 75:813-20. 2007
    ..We hypothesised that the MMP-3 polymorphism (- 1171, 5A/6A) would relate to coronary plaque characteristics and unstable clinical presentation...
  8. doi request reprint The effect of intended duration of clopidogrel use on early and late mortality and major adverse cardiac events in patients with drug-eluting stents
    Michelle J Butler
    Department of Cardiology at the Alfred Hospital, Melbourne, Victoria, Australia
    Am Heart J 157:899-907. 2009
    ..Our objective was to determine whether the planned duration of clopidogrel at the time of percutaneous coronary intervention affected patient outcomes...
  9. doi request reprint Usefulness of cooling and coronary catheterization to improve survival in out-of-hospital cardiac arrest
    Dion Stub
    Alfred Hospital Heart Centre, Melbourne, Victoria, Australia
    Am J Cardiol 107:522-7. 2011
    ..In conclusion, modern management of OHCA, including therapeutic hypothermia and early coronary angiography is associated with significant improvement in survival to hospital discharge and neurologic recovery...
  10. doi request reprint Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome
    Natalie G Lumsden
    Vascular Pharmacology and Heart Failure, Baker IDI Heart and Diabetes Institute, Melbourne, Vic, Australia
    Diab Vasc Dis Res 10:368-74. 2013
    ..In addition, these patients continue to present with endothelial dysfunction despite having lower levels of EMPs...
  11. ncbi request reprint Determinants of coronary artery compliance in subjects with and without angiographic coronary artery disease
    James A Shaw
    Alfred and Baker Medical Unit, Alfred Hospital and Baker Medical Research Institute, Melbourne, Australia
    J Am Coll Cardiol 39:1637-43. 2002
    ..The goal of this study was to determine factors contributing to the biomechanical properties of coronary arteries in people with and without angiographic coronary artery disease (CAD)...